메뉴 건너뛰기




Volumn 17, Issue 1, 2017, Pages 60-64

ANCA-associated vasculitis

Author keywords

ANCA; Diagnosis; Rituximab; Treatment; Vasculitis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; MYCOPHENOLATE MOFETIL; RITUXIMAB; ANTIRHEUMATIC AGENT;

EID: 85016025539     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.17-1-60     Document Type: Article
Times cited : (163)

References (20)
  • 1
    • 0000652834 scopus 로고
    • Segmental necrotising glomerulonephritis with antineutrophil antibody: Possible arbovirus aetiology?
    • Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J 1982; 285 : 606.
    • (1982) Br Med J , vol.285 , pp. 606
    • Davies, D.J.1    Moran, J.E.2    Niall, J.F.3    Ryan, G.B.4
  • 2
    • 84871251698 scopus 로고    scopus 로고
    • Revised international chapel hill consensus conference nomenclature of vasculitides
    • Jennette JC, Falk RJ, Bacon PA et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65 : 1 - 11.
    • (2012) Arthritis Rheum , vol.65 , pp. 1-11
    • Jennette, J.C.1    Falk, R.J.2    Bacon, P.A.3
  • 4
    • 84926615364 scopus 로고    scopus 로고
    • Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
    • Watts RA, Mahr A, Mohammad AJ et al. Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant 2015; 30( Suppl 1): i14-i22.
    • (2015) Nephrol Dial Transplant , vol.30 , pp. i14-i22
    • Watts, R.A.1    Mahr, A.2    Mohammad, A.J.3
  • 5
    • 84918575913 scopus 로고    scopus 로고
    • Damage in the anca-associated vasculitides: Long-term data from the European vasculitis study group (EUVAS) therapeutic trials
    • Robson J, Doll H, Suppiah R et al. Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials. Ann Rheum Dis 2015; 74 : 177 - 84.
    • (2015) Ann Rheum Dis , vol.74 , pp. 177-184
    • Robson, J.1    Doll, H.2    Suppiah, R.3
  • 6
    • 72249087511 scopus 로고    scopus 로고
    • Modification and validation of the birmingham vasculitis activity score (version 3)
    • Mukhtyar C, Lee R, Brown D et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 2009; 68 : 1827 - 32.
    • (2009) Ann Rheum Dis , vol.68 , pp. 1827-1832
    • Mukhtyar, C.1    Lee, R.2    Brown, D.3
  • 7
    • 84976590642 scopus 로고    scopus 로고
    • Can an increase in anti-neutrophil cytoplasmic autoantibody titer predict relapses in anti-neutrophil cytoplasmic antibody associated vasculitis?
    • Koh JH, Kemna MJ, Cohen Tervaert JW, Kim WU. Can an increase in anti-neutrophil cytoplasmic autoantibody titer predict relapses in anti-neutrophil cytoplasmic antibody associated vasculitis? Arthritis Rheum 2016; 68; 1571 - 3.
    • (2016) Arthritis Rheum , vol.68 , pp. 1571-1573
    • Koh, J.H.1    Kemna, M.J.2    Cohen, T.J.W.3    Kim, W.U.4
  • 8
    • 34248218149 scopus 로고    scopus 로고
    • EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: Focus on anti neutrophil cytoplasm antibody associated vasculitis
    • Hellmich B, Flossmann O, Gross WL et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti neutrophil cytoplasm antibody associated vasculitis. Ann Rheum Dis 2007; 66 : 605 - 17.
    • (2007) Ann Rheum Dis , vol.66 , pp. 605-617
    • Hellmich, B.1    Flossmann, O.2    Gross, W.L.3
  • 9
    • 0038122889 scopus 로고    scopus 로고
    • Arandomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies
    • Jayne D, Rasmussen N, Andrassy K et al. Arandomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003; 349 : 36 - 44.
    • (2003) N Engl J Med , vol.349 , pp. 36-44
    • Jayne, D.1    Rasmussen, N.2    Andrassy, K.3
  • 10
    • 84860920482 scopus 로고    scopus 로고
    • Pulse versus daily oral cyclophosphamide for induction of remission in ANCAassociated vasculitis: Long-term follow-up
    • Harper L, Morgan MD, Walsh M et al. Pulse versus daily oral cyclophosphamide for induction of remission in ANCAassociated vasculitis: long-term follow-up. Ann Rheum Dis 2012; 71 : 955 - 60.
    • (2012) Ann Rheum Dis , vol.71 , pp. 955-960
    • Harper, L.1    Morgan, M.D.2    Walsh, M.3
  • 11
    • 84928957372 scopus 로고    scopus 로고
    • BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis
    • Ntatsaki E, Carruthers D, Chakravarty K et al. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis . Rheumatology 2014; 53 : 2306 - 9.
    • (2014) Rheumatology , vol.53 , pp. 2306-2309
    • Ntatsaki, E.1    Carruthers, D.2    Chakravarty, K.3
  • 12
    • 84978946297 scopus 로고    scopus 로고
    • EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
    • Yates M, Watts RA, Bajema IM et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 2016; 75 : 1583 - 94.
    • (2016) Ann Rheum Dis , vol.75 , pp. 1583-1594
    • Yates, M.1    Watts, R.A.2    Bajema, I.M.3
  • 13
    • 77954651554 scopus 로고    scopus 로고
    • Rituximab versus cyclophosphamide for ANCA-associated vasculitis
    • Stone JH, Merkel PA, Spiera R et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010; 363 : 221 - 32.
    • (2010) N Engl J Med , vol.363 , pp. 221-232
    • Stone, J.H.1    Merkel, P.A.2    Spiera, R.3
  • 14
    • 77954632414 scopus 로고    scopus 로고
    • Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis
    • Jones RB, Tervaert JW, Hauser T et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010; 363 : 211 - 20.
    • (2010) N Engl J Med , vol.363 , pp. 211-220
    • Jones, R.B.1    Tervaert, J.W.2    Hauser, T.3
  • 15
    • 84954288948 scopus 로고    scopus 로고
    • Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)- Associated vasculitis based on ANCA type
    • Unizony S, Villarreal M, Miloslavsky EM et al. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)- Associated vasculitis based on ANCA type. Ann Rheum Dis 2016; 75 : 1166 - 9.
    • (2016) Ann Rheum Dis , vol.75 , pp. 1166-1169
    • Unizony, S.1    Villarreal, M.2    Miloslavsky, E.M.3
  • 16
    • 67650094918 scopus 로고    scopus 로고
    • A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis
    • Jones RB, Ferraro AJ, Chaudhry AN et al. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2009; 60 : 2156 - 68.
    • (2009) Arthritis Rheum , vol.60 , pp. 2156-2168
    • Jones, R.B.1    Ferraro, A.J.2    Chaudhry, A.N.3
  • 17
    • 23644455521 scopus 로고    scopus 로고
    • Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis
    • De Groot K, Rasmussen N, Bacon PA et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005; 52 : 2461 - 9.
    • (2005) Arthritis Rheum , vol.52 , pp. 2461-2469
    • De Groot, K.1    Rasmussen, N.2    Bacon, P.A.3
  • 18
    • 84868087895 scopus 로고    scopus 로고
    • Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibodyassociated vasculitis
    • Smith RM, Jones RB, Guerry MJ et al. Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibodyassociated vasculitis. Arthritis Rheum 2012; 64 : 3760 - 9.
    • (2012) Arthritis Rheum , vol.64 , pp. 3760-3769
    • Smith, R.M.1    Jones, R.B.2    Guerry, M.J.3
  • 19
    • 84908576790 scopus 로고    scopus 로고
    • Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis
    • Guillevin L, Pagnoux C, Karras A et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med 2014; 371 : 1771 - 80.
    • (2014) N Engl J Med , vol.371 , pp. 1771-1780
    • Guillevin, L.1    Pagnoux, C.2    Karras, A.3
  • 20
    • 84904917293 scopus 로고    scopus 로고
    • The informational needs of patients with ANCA-associated vasculitis-development of an informational needs questionnaire
    • Mooney J, Spalding N, Poland F et al. The informational needs of patients with ANCA-associated vasculitis-development of an informational needs questionnaire. Rheumatology 2014; 53 : 1414 - 21.
    • (2014) Rheumatology , vol.53 , pp. 1414-1421
    • Mooney, J.1    Spalding, N.2    Poland, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.